Taysha Gene Therapies, Inc. (TSHA) Financial Ratios Annual - Discounting Cash Flows
TSHA
Taysha Gene Therapies, Inc.
TSHA (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
Price Ratios
Price to Earnings Ratio -15.87 -4.85 -1.84 -0.598 -2.51 -10.9 -798.2
Price to Sales Ratio 147.8 51.93 13.3 39.7 0 0 0
Price to Book Ratio 7.24 6.05 2.74 104.7 4.6 1.87 -6,593
Price to Free Cash Flow Ratio -10.95 -5.3 -2.56 -0.877 -3.16 -11.78 6,593
Price to Operating Cash Flow Ratio -18.73 -5.33 -2.81 -1.12 -3.75 -15.26 6,593
Price Earnings to Growth Ratio -5.71 0.077 0.025 0.032 -0.069 -0.001 0
EV to EBITDA -8.4 -3.96 -1.73 -0.578 0.498
Liquidity Ratios
Current Ratio 10.48 5.42 4.08 1.54 3.08 36.17 0.1
Quick Ratio 10.48 5.42 4.08 1.54 3.08 36.17 0.1
Cash Ratio 10.39 5.3 3.92 1.4 2.88 35.24 0
Debt Ratio 0.218 0.394 0.354 0.475 0.295 0 0
Debt to Equity Ratio 0.315 0.883 0.815 63.15 0.661 0 0
Long Term Debt to Capitalization 0.188 0.381 0.351 0.976 0.281 0 0
Total Debt to Capitalization 0.24 0.469 0.449 0.984 0.398 0 0
Interest Coverage Ratio -1,399 -896.7 -14.49 -33.18 -121.3 -1,536 0
Cash Flow to Debt Ratio -1.23 -1.29 -1.19 -1.47 -1.86 0 0
Margins
Gross Profit Margin 95.47% 100% 100% 0.599% 0% 0% 0%
Operating Profit Margin -1,619% -1,098% -468.8% -5,037% 0% 0% 0%
Pretax Profit Margin -1,584% -1,072% -722.1% -6,635% 0% 0% 0%
Net Profit Margin -1,584% -1,072% -722.1% -6,635% 0% 0% 0%
Operating Cash Flow Margin -1,342% -974.7% -472.6% -3,533% 0% 0% 0%
Free Cash Flow Margin -1,350% -979.2% -520.3% -4,527% 0% 0% 0%
Return
Return on Assets -31.57% -55.68% -64.59% -131.5% -81.57% -16.61% -7,433%
Return on Equity -67.26% -124.8% -148.9% -17,494% -183% -17.11% 825.9%
Return on Capital Employed -35.47% -68.18% -53.27% -198.5% -106.8% -17.08% 825.9%
Return on Invested Capital 100.2% 2,112% 917.4% 466.7% 0% 0% 0%
Turnover Ratios
Receivables Turnover Ratio 0 0 0 0 0 0 0
Payables Turnover Ratio 0.053 0 0 0.227 0 0.005 0
Inventory Turnover Ratio 0 0 0 0 0 0 0
Fixed Asset Turnover Ratio 0.442 0.525 0.757 0.097 0 0 0
Asset Turnover Ratio 0.02 0.052 0.089 0.02 0 0 0
Per Share Items ()
Revenue Per Share 0.018 0.033 0.133 0.057 0 0 0
Operating Cash Flow Per Share -0.24 -0.325 -0.629 -2.01 -3.11 -1.74 0.004
Free Cash Flow Per Share -0.241 -0.326 -0.692 -2.58 -3.68 -2.25 0.004
Cash & Short Term Investments 0.842 0.556 1.24 2 3.96 14.22 0
Earnings Per Share -0.283 -0.357 -0.961 -3.78 0 0 0
EBITDA Per Share -0.286 -0.361 -0.612 -2.81 -4.59 -2.43 0.09
Dividend Per Share 0 0 0 0 0 0 0
Enterprise Value Per Share 2.4 1.43 1.06 1.62 -2.28 0 0
Book Value Per Share 0.421 0.286 0.645 0.022 0 0 0
Price Per Share 3.05 1.73 1.77 2.26 0 0 0
Effective Tax Rate 0% 0% 0% 0% 0% 0% 0%
Short Term Coverage Ratio 0 0 0 0 0 0 0
Capital Expenditure Coverage Ratio -174.2 -217.2 -9.91 -3.55 -5.43 -3.38 0
EBIT Per Revenue -16.19 -10.98 -4.69 -50.37 0 0 0
EBITDA Per Revenue -16 -10.83 -4.6 -49.38 None None None
Days of Sales Outstanding 0 0 0 0 0 0 0
Days of Inventory Outstanding 0 0 0 0 0 0 0
Days of Payables Outstanding 6,940 0 0 1,606 0 80,868 0
Cash Conversion Cycle -6,940 0 0 -1,606 0 -80,868 0
Cash Conversion Ratio 0.847 0.91 0.654 0.532 0 0 0
Free Cash Flow to Earnings 0.852 0.914 0.721 0.682 0 0 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program